Choline acetyltransferase variants and their influence in schizophrenia and olanzapine response

@article{Mancama2007CholineAV,
  title={Choline acetyltransferase variants and their influence in schizophrenia and olanzapine response},
  author={Dalu T Mancama and Ignacio F. Mata and R. W. Kerwin and Mar{\'i}a Jes{\'u}s Arranz},
  journal={American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year={2007},
  volume={144B}
}
  • D. MancamaI. Mata M. Arranz
  • Published 5 October 2007
  • Psychology, Biology
  • American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Choline acetyltransferase (ChAt) is extensively distributed throughout the CNS where, by catalyzing acetylcholine synthesis, it participates in modulating wide‐ranging cholinergic‐dependent functions including cognitive performance, sleep, arousal, movement, and visual information processing. Recently, compelling evidence has mounted implicating ChAt in schizophrenia. In particular, studies have identified significant reductions in ChAt activity in the nucleus accumbens and pontine tegmentum of… 

Genetic variants in the choline acetyltransferase (ChAT) gene are modestly associated with normal cognitive function in the elderly

The ChAT rs3810950 A allele was found to be associated with a decrease cognitive status evaluated by a five‐component cognitive composite score and Mini Mental State Examination at the lowest age, and was lower in the whole interval 73–82 although the absolute difference became smaller with age.

Role of the Central Cholinergic System in the Therapeutics of Schizophrenia

  • A. Terry Jr.
  • Psychology, Medicine
    Current Neuropharmacology
  • 2008
It is important that cholinergic function in schizophrenia be further elucidated and that the mechanisms of the chronic effects of antipsychotic drugs on this important neurotransmitter system be identified.

Role of the central cholinergic system in the therapeutics of schizophrenia.

  • A. Terry
  • Psychology, Medicine
    Current neuropharmacology
  • 2008
It is important that cholinergic function in schizophrenia be further elucidated and that the mechanisms of the chronic effects of antipsychotic drugs on this important neurotransmitter system be identified.

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

This study has generated several novel candidate genes for antipsychotic response and will require replication and functional validation, and provides all GWAS p-values for download.

Choline acetyltransferase may contribute to the risk of Tourette syndrome: Combination of family-based analysis and case–control study

  • Xiuling YangWenmiao Liu Tang Li
  • Biology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2018
The association analysis demonstrates that CHAT may contribute to TS susceptibility in the Han Chinese population and gives strong support to the involvement of cholinergic interneurons in the aetiology of TS and reveals a potential therapeutic target.

Convergent Evidence that Choline Acetyltransferase Gene Variation is Associated with Prospective Smoking Cessation and Nicotine Dependence

The ability to quit smoking is heritable, yet few genetic studies have investigated prospective smoking cessation. We conducted a systems-based genetic association analysis in a sample of 472

Genomewide Pharmacogenomic Analysis of Response to Treatment with Antipsychotics

The potential of genome-wide association studies to discover novel genes that mediate the effects of antipsychotics, which could eventually help to tailor drug treatment to schizophrenic patients is demonstrated.

References

SHOWING 1-10 OF 26 REFERENCES

Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions.

Mesopontine ChAT concentrations are depressed in schizophrenia and correlate significantly with measures of cognitive performance in patients with this disorder.

Choline acetyltransferase in schizophrenia.

The lower concentration of choline acetyltransferase in the pontine tegmentum of schizophrenic subjects compared with comparison subjects suggests involvement of pontine cholinergic neurons in schizophrenia.

Possible changes in striatal and limbic cholinergic systems in schizophrenia.

An alternative hypothesis proposes that the high levels are a compensatory response to defective cholinergic receptors in the affected areas, and by analogy with chorea, dopaminergic antagonists would act in schizophrenia by helping to reestablish cholinerential-dopaminergic balance.

Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population

Interactions between histaminergic and cholinergic systems in learning and memory

Choline acetyltransferase: The structure, distribution and pathologic changes in the central nervous system

  • Y. Oda
  • Biology
    Pathology international
  • 1999
Central cholinergic neurones are involved in several neurodegenerative diseases such as Alzheimer’s disease and amyotrophic lateral sclerosis, in which disturbance of the central ChAT system does not appear to be closely related to the etiology, but rather to the development of clinical symptoms.

Cholinergic function and dysfunction in the visual system.

  • M. BeelkeW. Sannita
  • Biology, Psychology
    Methods and findings in experimental and clinical pharmacology
  • 2002
Viewing all these data as a whole, nonspecific ACh actions on cognition, such as arousal or attention, contribute in modulating the function-specific action of ACh in information processing, both at cognitive and visual level.